PODCAST: The 10 Top Technology Trends Shaping the Future of the Pharma

THE CULTURAL SHIFT

Dr. Bertalan Meskó, MD

The pharma industry has taken a big swung into digital transformation. All participants invest in digital health topics.

But as with all trending issues, and there is a lot of fuss that is hard to see through. As the medical community increasingly acknowledges the importance of digital health, the cultural shift we so often talk about is still a way to go. To change that, the first step is always getting to know what’s coming.

In this article, with podcast, Bert collected the trends changing the pharmaceutical industry.

ESSAY AND PODCAST: https://medicalfuturist.com/top-10-trends-shaping-future-pharma/?utm_source=The%20Medical%20Futurist%20Newsletter&utm_campaign=3a501b1978-EMAIL_CAMPAIGN_2021_09_05_Resend&utm_medium=email&utm_term=0_efd6a3cd08-3a501b1978-399696053&mc_cid=3a501b1978&mc_eid=40fee31c25#

YOUR THOUGHTS AND COMMENTS ARE APPRECIATED.

Thank You

***

****

PODCAST: Health Insurance Carrier STOCK EARNINGS CALLS

BY ERIC BRICKER MD

***

***

YOUR COMMENTS ARE APPRECIATED.

CITE: https://www.r2library.com/Resource/Title/0826102549

Thank You

***

***

***

PODCAST: Surescripts Explained

Gate Keeper for Electronic Prescribing

BY DR. ERIC BRICKER
****

***

YOUR COMMENTS ARE APPRECIATED.

Thank You

***

***

PODCAST: Medicare Part D [Rx Drugs]

LATE ENROLLMENT PENALTY CALCULATIONS

Medicare – CMS

CITE: https://www.r2library.com/Resource/Title/0826102549

****

***

YOUR COMMENTS ARE APPRECIATED.

***

Thank You

***

PODCAST: APPEALS Traditional [Original] Medicare

BY CMS

***

***
YOUR COMMENTS ARE APPRECIATED.

Thank You

***

***

PODCAST: Understanding Your Medicare Choices

ORIGINAL MEDICARE, PART C, MEDIGAP AND YOU

CITE: https://www.r2library.com/Resource/Title/0826102549

BY MEDICARE – CMS

***

***

YOUR COMMENTS ARE APPRECIATED.

Thank You

***

***

PODCAST: The Four [4] Parts of Medicare

UNDERSTAND AND KNOW THE DIFFERENCE: A, B C & D

CITE: https://www.r2library.com/Resource/Title/0826102549

BY MEDICARE – CMS

***

***
YOUR COMMENTS ARE APPRECIATED.

Thank You

***

PODCASTS: FDA Pharmaceutical Industry Ties

CONFLICTS OF INTEREST?

The New York Times Had an Excellent Article on the FDA on September 2, 2021.

The Article Described How the FDA Began Receiving Funding from the Pharmaceutical Industry Itself to Pay for FDA Employee Salaries in 1992–a Potential Conflict-of-Interest. Subsequently, a Study Found that 1/3 of Drugs Approved by the FDA Were Found to Have Safety Problems from 2000 -2010. Another Potential Conflict-of-Interest is Number of FDA Regulators Who Leave Their Positions to Take High-Paying Jobs at Pharmaceutical Companies.

By Eric Bricker MD

FDA rescinds emergency authorization for COVID-19 antibody treatment  bamlanivimab | TheHill

PODCAST:

***

YOUR COMMENTS ARE APPRECIATED.

Thank You

****

***

What’s the Latest on MEDICARE DRUG PRICE Negotiations?

BY KFF

Prescription drug costs are a major concern for consumers and a fiscal challenge for public and private payers, representing 10% of national health spending and nearly 20% of health benefit costs for large employers and Medicare.

In response, lawmakers are considering a broad range of policy options, including one that would allow the federal government to negotiate prescription drug prices on behalf of Medicare beneficiaries and people enrolled in private plans, a proposal that has strong bipartisan public support.

CITE: https://www.r2library.com/Resource/Title/0826102549

****

Could Negotiating Medicare Drug Prices Save $300 Billion Per Year? |  Committee for a Responsible Federal Budget

This brief describes the current status of drug price negotiation proposals, looks back at the history of proposals to give the federal government the authority to negotiate drug prices in Medicare, describes the negotiation provisions in key legislation (H.R. 3), and discusses the potential spending effects for the federal government and individuals.

READ: https://www.kff.org/medicare/issue-brief/whats-the-latest-on-medicare-drug-price-negotiations/

UPDATE: https://www.msn.com/en-us/news/politics/medicare-trustees-sound-alarm-but-progressives-press-ahead-with-irresponsible-medicare-expansion/ar-AAOh6EA?li=BBnb7Kz

YOUR THOUGHTS AND COMMENTS ARE APPRECIATED.

Thank You

***

****

PODCAST: Hospital 340-B Drug Programs

BY ERIC BRICKER MD

YOUR COMMENTS ARE APPRECIATED.

KFF MORE: https://www.kff.org/medicare/issue-brief/whats-the-latest-on-medicare-drug-price-negotiations/

HRSA MORE: https://www.hrsa.gov/opa/index.html

Thank You

***

PODCAST: Using “GoodRx” to Check Prescription Prices

BY ERIC BRICKER MD

YOUR THOUGHTS AND COMMENTS ARE APPRECIATED.

Thank You

CITE: https://www.r2library.com/Resource/Title/0826102549

***

PODCAST: Richard Sackler’s Testimony About Purdue Pharma and the Opioid Crisis

BY PROPUBLICA

Investigative Journalism in the Public Interest

***

NY, other states announce $4.5B settlement with Purdue Pharma and Sackler  family | WXXI News

***

A settlement is about to shield members of the Sackler family from civil litigation regarding their alleged roles in the opioid crisis. So it’s a good time to release the full video of Richard Sackler’s 2015 deposition.

PODCAST: https://www.propublica.org/article/we-are-releasing-the-full-video-of-richard-sacklers-testimony-about-purdue-pharma-and-the-opioid-crisis?utm_source=sailthru&utm_medium=email&utm_campaign=dailynewsletter&utm_content=feature

Your comments are appreciated.

THANK YOU

***

The PBMI Innovation Challenge

There’s still time!
Submit your innovative solution in patient health management to the Pharmacy Benefit Management Institute (PBMI) Innovation Challenge by August 6, 2021 for the chance to be among one of the 5 finalists selected to pitch their ideas before a panel of judges at the PBMI 2021 Annual Meeting!




Be sure to submit your idea by August 6, 2021 for the chance to be featured in an upcoming issue of Managed Healthcare Executive with a full-year integrated marketing program valued at over $100K, in addition to formal acknowledgment at this year’s PBMI Conference.

REGISTER: https://events.pbmi.com/event/31593a7e-d661-4ea5-abf2-5aa6473e1a14/summary

***

PODCAST: PBM Formulary Waste Exposed in Commonwealth Fund Study

15 Self-Funded Employers Analyzed Their Pharmacy Claims Data in Conjunction with the Commonwealth Fund and Discovered the Following Regarding their PBM FormularIES

***

***

YOUR THOUGHTS ARE APPRECIATED

Thank You

***

PODCAST: Laboratory Test Costs in EHRs and Physician Behavior


Johns Hopkins Hospital Listed the Cost of 61 Lab Tests on Doctors’ Computer Screens … While They Were Ordering Labs.



By Dr. Eric Bricker MD

Results:

–Just Seeing the Cost of the Lab Test DECREASED the Number of Labs Ordered Per Patient by 9%.

–Doctors Also SUBSTITUTED a Lower Cost Lab Test for a Higher Cost Lab Test 10,000 Times.

The Doctors Were NOT Clinically Directed to Change Their Behavior.

The Doctors’ Pay Was NOT Affected by Their Lab Ordering Either Way.

This Study Illustrates How Giving Doctors Cost Information in a Setting of Clinical and Financial Independence AUTOMATICALLY Decreases Healthcare Waste.

Doctors Can Be Much Better Stewards of Healthcare Dollars … and the Technological Innovation Needed is Minimal.

Disclosure: Dr. Bricker is the Chief Medical Officer of Virtual Care Company First Stop Health.

YOUR COMMENTS ARE APPRECIATED.

Thank You

***

PODCAST: Novartis Drug Company Settlement with the USA

Why SOME Doctors Take Money from Pharmaceutical Companies

Q&A: Eric Bricker, chief medical officer of Compass patient advocacy service - Dallas Business ...

BY ERIC BRICKER MD

MAssive Global Drug Company Novartis Paid $678M to Settle Charges from the US Federal Government.

The Charges Were Regarding Illegal Payments and Kickbacks to Doctors that Were Thinly-Veiled as ‘Speaker Fees’ and Fancy Dinners.

Why Where the Doctors Not Held Accountable and What Does This Say About a Doctor’s Mentality on Money?

Learn the Psychology of Doctors and Money.

Understand How It Leads to Counterproductive Relationships Between Physicians and Drug Companies, Which Can Compromise the #1 Rule in Medicine: The Patient Comes First, Always.

Disclaimer: Dr. Bricker is the Chief Medical Officer of Virtual Care Company First Stop Health

YOUR THOUGHTS ARE APPRECIATED

Thank You

***

On CRISPR Gene Editing

DEFINITION: CRISPR is a family of DNA sequences found in the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments of bacteriophages that had previously infected the prokaryote. They are used to detect and destroy DNA from similar bacteriophages during subsequent infections

CITE: https://www.amazon.com/Dictionary-Health-Information-Technology-Security/dp/0826149952/ref=sr_1_5?ie=UTF8&s=books&qid=1254413315&sr=1-5

***

A Gene Editing Breakthrough
For the first time, CRISPR technology has been used to successfully treat disease in vivo, or inside the human body.

That big medical news was announced Saturday by the biotech startup Intellia Therapeutics and its partner Regeneron, which said their gene-editing techniques reduced the amount of harmful liver protein associated with a genetic nerve disorder. 

What is CRISPR? It stands for “clustered regularly interspaced short palindromic repeats,” and it’s one of those things humans found in nature and then copied.  Bacteria use CRISPR to repel viruses, but humans have harnessed it to ctrl+c, ctrl+v DNA sequences, potentially leading to a revolution in treating disease.  The two scientists who made that breakthrough in 2012, Jennifer Doudna and Emmanuelle Charpentier, won the Nobel Prize in Chemistry last year (Doudna is also a cofounder of Intellia).

Quote du jour: “There’s a feeling like we’re walking through a door here into all kinds of new possibilities. And there’s not many moments in medicine where you get to experience that,” Intellia CEO John Leonard said.  Looking ahead…expect Intellia shares, which have gained 233% since its 2016 IPO, to pop.

CRISPR/Cas9 Genome Editing Technique - Musicians4Freedom

****

ASSESSMENT: Your thoughts are appreciated.

INVITE DR. MARCINKO: https://medicalexecutivepost.com/dr-david-marcinkos-

CONTACT: Ann Miller RN MH

[Executive Director]

THANK YOU

***

On Higher Prescription Drug Cost-Sharing and Mortality?

Raises Mortality among Medicare PART D Beneficiaries

QUERY: What are the health consequences when patients reduce their use of prescribed medications in response to higher out-of-pocket costs?

w28439.jpg

In The Health Costs of Cost-Sharing (NBER Working Paper 28439), researchers Amitabh Chandra, Evan Flack and Ziad Obermeyer use the distinctive out-of-pocket cost-sharing features of Medicare Part D to demonstrate that such reductions can increase mortality.

ASSESSMENT: Your thoughts are appreciated.

THANK YOU

***

PODCAST: Fundamentals of Healthcare Finance

Today’s Video is a Fundamental of Healthcare Finance That Every Professional Must Understand… and that Most Consumers DO NOT.

***

2021 Medical Captive Forum | Roundstone Insurance

BY ERIC BRICKER MD

The Formulary is the List of Medications That Are Covered by Health Insurance.  Not All Medications Are Covered. The Doctor Does Not Know What Medications Are or Are Not on Their Patients’ Formularies. However, the Pharmacy Does Via Computer Software That They Use.

Citation: https://www.r2library.com/Resource/Title/0826102549

***

Formularies Have Many Rules Associated With Them:

1) Prior Authorization – Approval Must Be Given by the Health Insurance Company/PBM Before They Agree to Pay for a Medication.

2) Step Therapy – Certain Less Expensive Generic Medications Have to Be ‘Tried’ First and Fail Before a Doctor Can Prescribe a More Expensive Brand-Name Medication.

3) Mandatory Generics – If a Brand Name Medication Has A Direct Generic Equivalent, Then the Insurance May Only Agree to Pay for the Generic and Not the Brand.

4) Mandatory Mail Order – Certain Chronic Medications That Are Filled for 90 Day Supplies Must Be Filled via Mail Order and Not at the Retail Pharmacy.

ASSESSMENT: Your thoughts are appreciated.

THANK YOU

***

PODCAST: The Domestic Opioid Epidemic

A Post Pandemic OVERDOSE AND ADDICTION Update

By NIHCM Foundation

The opioid epidemic continues to devastate communities, with provisional data showing overdose death rates rising during the pandemic. Isolation and economic upheaval, as well as hindered access to treatment options and support systems, have increased the risk of addiction and relapse. These new pressures exist along with the stigma that often prevents people from receiving care for substance use disorder (SUD) and the ongoing need to adopt harm reduction strategies.

Speakers Discuss:

  • The latest federal priorities for addressing the overdose and addiction epidemic, including a focus on harm reduction efforts and ensuring racial equity in drug policy
  • Strategies for state agencies to meet existing and increasing SUD treatment needs
  • A health plan’s innovative approaches to expand SUD care through an in-home addiction treatment program and recovery coaches

Opioid use in Larimer County continues as drug becomes ...

ASSESSMENT: And so, this podcast / webinar further explores solutions to reduce overdose rates, with a focus on efforts to expand access to evidence-based recovery programs after the corona virus pandemic.

PODCAST / WEBINAR HERE: https://nihcm.org/publications/addressing-the-growing-overdose-and-addiction-epidemic?utm_source=NIHCM+Foundation&utm_campaign=f78ae3a137-05242021_Webinar_Archive&utm_medium=email&utm_term=0_6f88de9846-f78ae3a137-167744768

Your thoughts and comments are appreciated.

THANK YOU

***

PODCAST: “Cash Pay” Pharmacy

Owner of Independent Pharmacy

This image has an empty alt attribute; its file name is 48-300x300.png

EDITOR’S NOTE: We’ve written, posted and opined on concierge and retail medicine; cash based care and direct primary care medicine, and related machinations before on this ME-P. Now, Shawn Needham and his wife, Janet, discuss starting their own, independent pharmacy in the late ’90s. At first glance, this is a success story for an independent pharmacy but Shawn explains what makes their pharmacy different in a big way.

-Dr. David E. Marcinko MBA CMP®

[Eidtor-in-Chief]

PODCAST: https://healthcareamericana.com/episode/shawn-needham-cash-pay-pharmacy/

RELATED EXAMPLE: https://www.pharmacytoday.org/action/showPdf?pii=S1042-0991%2821%2900299-1

ASSESSMENT: Your thoughts are appreciated.

THANK YOU

***

A General Electric Healthcare [Physician] Investor Update

Enabling precision health PODCAST

Hi David, and all ME-P Readers and Subscribers

We’re proud to be a part of improving patient lives globally with precision health – personalizing diagnoses and treatments in a smarter and more efficient way.

In case you missed it, last week GE Healthcare’s Pharmaceutical Diagnostics business (PDx) announced the acquisition of Zionexa, a leading innovator of in-vivo oncology and neurology biomarkers that help enable more personalized healthcare.

Healthcare will scale Zionexa’s FDA-approved PET imaging agent Cerianna, which is used as an adjunct to biopsy for the detection of estrogen receptor (ER) positive lesions to help inform treatment selection for patients with recurrent or metastatic breast cancer.

This is the essence of precision health, and our continued commitment to innovation. Read more about Zionexa here.

And, as a reminder, Carolina will be participating in a fireside chat on May 12 at 12:10pm EDT during the Goldman Sachs Industrials & Materials Conference. We hope you and all interested ME-P readers and subscribers will tune in.

GE Healthcare logo

Best,
Steve Winoker

[GE Corporate]

Boston, MA

PHARMACISTS: Leaving this Public Health Workforce

By NIHCM Foundation

This infographic takes a close look at the pharmacist workforce and its role in the COVID-19 response.

Pharmacists are trusted and accessible, with 90% of Americans living within five miles of a pharmacy. They are well-positioned to address vaccine hesitancy and ensure equitable COVID-19 vaccine distribution and access. Leveraging and supporting pharmacists could help address public health priorities both during and after the corona virus pandemic.

Hello Psychologist Career Counselling Centre - 9369160546 ...

LINK: https://nihcm.org/publications/pharmacist-infographic

OPIOID CRISIS RISING: https://medicalexecutivepost.com/2019/08/22/the-opioid-crisis-rising-2000-2017/

OPIOID CRISIS COSTS: https://medicalexecutivepost.com/2019/10/20/the-opioid-epidemic-cost-distribution/

OPIOID CRISIS PODCAST: https://freemanbeyondthewall.libsyn.com/episode-169-the-opioid-crisis

Your thoughts are appreciated.

THANK YOU

***

Mark Cuban Launches Generic Drug Company

COST PLUS Drug Company

[By Staff Reporters]

The company’s first drug is antiparasitic drug albendazole but plans to offer over 100 additional drugs by the end of 2021.

LINK: https://costplusdrugs.com/

Product Details

Your thoughts are appreciated.

THANK YOU

***

World Bi-Polar Day 2021

By staff reporters

Bipolar disorder, formerly called manic depression, is a mental health condition that causes extreme mood swings that include emotional highs (mania or hypomania) and lows (depression).

When you become depressed, you may feel sad or hopeless and lose interest or pleasure in most activities. When your mood shifts to mania or hypomania (less extreme than mania), you may feel euphoric, full of energy or unusually irritable. These mood swings can affect sleep, energy, activity, judgment, behavior and the ability to think clearly.

Episodes of mood swings may occur rarely or multiple times a year. While most people will experience some emotional symptoms between episodes, some may not experience any.

Although bipolar disorder is a lifelong condition, you can manage your mood swings and other symptoms by following a treatment plan. In most cases, bipolar disorder is treated with medications and psychological counseling (psychotherapy).

***

Corona Vaccine Food for Thought

Vaccine

By Anonymous

***

****

cv

Long-Terms Effects of Covid-19

Long-Terms Effects of Covid-19

By staff reporters

***

***

MORE:

The short-term, middle-term, and long-term future of the coronavirus

How the Vaccines Work?

PFIZER-BioNTech and MODERNA

By staff reporters

***

***

The Health Economics of INSULIN

Read the Grassley-Wyden Report

Grassley-Wyden Insulin Report (FINAL).pdf (senate.gov)

Your comments are appreciated.

THANK YOU

***

Cumulative Covid-19 Vaccination Doses Administered to-Date!

2021 Vaccine Equity

January 16, 2021

***

***

A New Corona Virus Variant?

A Rapid Rise in COVID-19 Cases?

By CDC.gov

***

***

The Pre-Vaccine Era

ESTIMATED ANNUAL MORBIDITY IN THE USA

By staff reporters

***

 

***

VACCINE COMPARISON: Pfizer-BioNet V. Moderna

Comparison with Commonalities

By Staff reporters

***

 

***

The CORONA PANDEMIC 2020 – 2021

Defense versus Offense

***

***

COVID-19 Vaccine?

WHAT’S IN IT – AND WHY?

By Un-Biased Science

***

***

Systemic Racism & Health Care, COVID & Treatment

COVID-19 [NIHCM]

By staff reporters

***

https://nihcm.org/publications/systemic-racism-health-care-covid-treatment?utm_source=NIHCM+Foundation&utm_campaign=c7ef174251-EMAIL_CAMPAIGN_2020_12_02_02_53&utm_medium=email&utm_term=0_6f88de9846-c7ef174251-167744768

***

 

 

The “Cytokine” Storm [hypercytokinemia]?

Hypercytokinemia and Covid-19

By staff reporters

A cytokine storm, also called hypercytokinemia, is a physiological reaction in humans and other animals in which the innate immune system causes an uncontrolled and excessive release of pro-inflammatory signaling molecules called cytokines.

Normally, cytokines are part of the body’s immune response to infection, but their sudden release in large quantities can cause multisystem organ failure and death.

Cytokine storms can be caused by a number of infectious and non-infectious etiologies, especially viral respiratory infections such as H5N1 influenza, SARS-CoV-1, and SARS-CoV-2. Other causative agents include the Epstein-Barr virus, cytomegalovirus, and group A streptococcus, and non-infectious conditions such as graft-versus-host disease.

***

***

Covid-19 Test Accuracy?

UPDATE

By staff reporters

***

***

2021 Prescription Drug Payment Model from HHS

Administration Announces Prescription Drug Payment Model
***
By staff reporters
***
HHS Secretary Alex Azar has announced a drug payment model through the Center for Medicare and Medicaid Innovation at the Centers for Medicare & Medicaid Services that will lower Medicare Part B payments for certain drugs to the lowest price for similar countries and save American taxpayers and beneficiaries more than $85 billion over seven years.
***
***
Starting in January, the model, known as the Most Favored Nation (MFN) Model, will test an innovative way for Medicare to pay no more for high cost, physician-administered Medicare Part B drugs than the lowest price charged in other similar countries.
***
Following the President’s recent Executive Orders to lower drug prices and improve access to life-saving medications, the MFN Model will protect current beneficiary access to Medicare Part B drugs, make them more affordable, and address the disparity of drug costs between the U.S. and other countries.
***
Source: CMS [11/20/20]

What is the “Good-Rx” Business Model?

By Anonymous

Good Rx makes money by perpetuating the, artificially set, high sticker prices of medications and receiving a portion of Pharmacy Benefits Manager [PBM] fees.

How it Works

GoodRx taps into PBM network for their “discounts” off of sticker price (e.g. Express Scripts, Optum Rx, Navitus … etc)

Consumer pays the newly “discounted” drug price.

Pharmacy pays PBM fee.

PBM pays GoodRx portion of the fee.

Good Rx adjusted EBITDA in 2019: $160 Million

Good Rx 2020 revenue is up 48% first half of 2020 – $257M

IPO: https://mobile-reuters-com.cdn.ampproject.org/c/s/mobile.reuters.com/article/amp/idUSKBN24Y0N6

Opinion:

This is not market value.

This is another hand in the cookie jar keeping healthcare prices artificially high.

The consumer is the one ultimately harmed.

***

Product DetailsProduct Details

CMS Value Based Purchasing for Drugs

CMS Proposed Rule Supports Value-Based Purchasing for Drugs

Courtesy: www.CertifiedMedicalPlanner.org

On June 19, 2020 the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule regarding Medicaid Drug Rebate Program (MDRP) regulations, with the aim of lowering drug prices, increasing patient access, and encouraging innovation in the insurance and pharmaceutical industries.

This proposal is consistent with the Trump Administration’s Blueprint to Lower Drug Prices (Blueprint) released in May 2018, in which the administration highlighted its goal to “avoid excessive pricing by relying more on value-based pricing by expanding outcome-based payments in Medicare and Medicaid” and to “speed access to and lower the cost of new drugs by clarifying policies for sharing information between insurers and drug makers.”

***

***

The proposed rule seeks to accomplish the Blueprint’s goals by reducing regulatory barriers that have previously prevented commercial plans and states from entering into value-based purchasing (VBP) arrangements with drug manufacturers.

Colleagues from Health Capital Consultants, LLC; explain.

ESSAY: DRUGS

Assessment: Your thoughts and comments are appreciated.

BUSINESS, FINANCE, INVESTING AND INSURANCE TEXTS FOR DOCTORS:

1 – https://lnkd.in/ebWtzGg

2 – https://lnkd.in/ezkQMfR

3 – https://lnkd.in/ewJPTJs

THANK YOU

***

Medical Practice “Prior Authorizations”

THE “SIREN CALL” OF MEDICAL PRACTICE PRIOR AUTHORIZATONS

Courtesy: www.CertifiedMedicalPlanner.org

“The Doctor Can’t See You – She’s Too Busy Doing Prior Authorizations.”

By Dr. David Edward Marcinko MBA

Somewhere along the way, physicians took a wrong step. Colleagues said OK to the SERPENT who whispered: “this saves money,” and now we’re entangled. We should’ve asked, “Whose money?”

PRIOR AUTHORIZATIONS for medical treatment and prescription drug are killing medicine and all those who would follow into this once great profession.

LINK: https://www.amazon.com/Dictionary-Health-Insurance-Managed-Care/dp/0826149944/ref=sr_1_4?ie=UTF8&s=books&qid=1275315485&sr=1-4

And so, here is an excerpt [blinded and abbreviated] from an email we received from a medical physician colleague.

***

DOCTOR: For every hour that I spend with a patient, I spend another three hours documenting and begging.
TYPICAL DAY: 4 hours of seeing patients, sprinkled between 12 hours of doing what we used to call “paperwork”.

EMRs: Calling it Electronic Medical Records and data collection doesn’t make this nonsense any more appealing.
ASSESSMENT: Patients get turned away because PCPs are too busy with paperwork. People are sick and dying while I’m calling clerks and pleading for RXs. I’d rather be doctoring.
BOTTOM LINE: 1/5 of my day, over 12 hours a week as a PCP, is now spent on prior authorizations. 1/3 of my assistant’s day is on prior authorizations. That’s why he couldn’t call you back.

CONCLUSION: Next time you can’t get a doctor’s appointment, you’ll know why.

***

Assessment: Your thoughts and comments are appreciated.

BUSINESS, FINANCE, INVESTING AND INSURANCE TEXTS FOR DOCTORS

1 – https://lnkd.in/ebWtzGg

2 – https://lnkd.in/ezkQMfR

3 – https://lnkd.in/ewJPTJs

THANK YOU

***

The Power of Pharmaceuticals

Spending Outpaces Inpatient Hospital Spending

CIRCA: 2018-2019

By Staff Reporters

***

***

Product DetailsProduct DetailsProduct Details

***

23 Potential COVID-19 Drugs

COVID-19 Drugs

[By staff reporters]

Drugs being studied in clinical trials. 30+ drug candidates in preclinical research phase.

There is HOPE!

***

***

Disclaimer – For informational purposes only; should not be considered medical advice; consult a healthcare professional. Drugs shown are not yet approved for use to treat COVID-19 but are being investigated for use in clinical trials.

***

Corona Virus Economics

***

******

THANK YOU

 

Insurers, PBMs and Specialty Pharmacies Today

CIRCA: 2019 Vertical Business Relationships

***

***

Conclusion: Your thoughts are appreciated.

Product DetailsProduct DetailsProduct Details

***

The Drug Pricing “Theory of Relativity”

ONE SIGN SAYS IT ALL

[By staff reporters]

***

***

Product DetailsProduct Details

***

National Prescription Drug Take Back Day

October 26, 2019 – 10:AM to 2:PM

The National Prescription Drug Take Back Day aims to provide a safe, convenient, and responsible means of disposing of prescription drugs, while also educating the general public about the potential for abuse of medications.

Prescription Pill Bottles

MORE: https://www.bing.com/videos/search?q=dea+take+back+day&&view=detail&mid=0D5B986D9C5FD79B077B0D5B986D9C5FD79B077B&&FORM=VRDGAR

MORE: https://takebackday.dea.gov/

Conclusion

Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.

Link: http://feeds.feedburner.com/HealthcareFinancialsthePostForcxos

Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com

Ambulance DEM

***

The Opioid Epidemic Cost Distribution?

FY: 2015 – 2018

By http://www.MCOL.com

***

***

***

Conclusion

Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.

Link: http://feeds.feedburner.com/HealthcareFinancialsthePostForcxos

Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com

***

Product DetailsProduct Details

A BLACK MARKET PODCAST VIEW OF THE OPIOID CRISIS

A BLACK MARKET PODCAST VIEW OF THE OPIOID CRISIS

Courtesy: www.CertifiedMedicalPlanner,org

Opioid Overdose Crisis

Every day, more than 130 people in the United States die after overdosing on opioids.1 The misuse of and addiction to opioids—including prescription pain relievers, heroin, and synthetic opioids such as fentanyl used to help relieve severe ongoing pain —is a serious national crisis that affects public health as well as social and economic welfare.

***

***

The Podcast

And so, I was fascinated with this podcast because I often encountered narcotic seeking patients while in city center and urban practice. It was recorded by my neighbor and Austrian economist Peter Raymond over at “The Free Man Beyond the Wall” website.

Colleague Dr. Mark Thornton recently gave this talk at the Mises Institute Supporters Summit on the opioid crisis that is plaguing the US. Dr. Thornton lays out a short history of this tragic epidemic that is taking lives every day. He addresses how doctors prescribe these drugs, how government regulates them and explains what happens when people are forced into the “black market” to sustain their addiction.

PODCAST: http://freemanbeyondthewall.libsyn.com/episode-169-the-opioid-crisis

MORE: https://medicalexecutivepost.com/2019/08/22/the-opioid-crisis-rising-2000-2017/

MORE: https://medicalexecutivepost.com/2019/02/06/about-the-opioid-crisis/

Your thoughts are appreciated.

BUSINESS, FINANCE AND ECONOMICS TEXTBOOKS FOR DOCTORS:

1 – https://lnkd.in/ebWtzGg

2 – https://lnkd.in/ezkQMfR

3 – https://lnkd.in/ewJPTJs

THANK YOU

Product DetailsProduct Details

***

%d bloggers like this: